(Q36716808)

15 August 2017

1 reference

title

Noninfectious granulomatous diseases: an update (English)

1 reference

15 August 2017

Leonid Izikson

1

1 reference

15 August 2017

Joseph C English

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2006

1 reference

15 August 2017

published in

Advances in dermatology

1 reference

15 August 2017

volume

22

1 reference

15 August 2017

page(s)

31-53

1 reference

Rheumatoid arthritis: a review of the cutaneous manifestations

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Interstitial granulomatous dermatitis with plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Interstitial granulomatous dermatitis with plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Interstitial granulomatous dermatitis with cutaneous cords and arthritis: a disorder associated with autoantibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Interstitial granulomatous dermatitis with arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Interstitial granulomatous dermatitis with plaques associated with antiphospholipid syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Interstitial granulomatous dermatitis secondary to soy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Interstitial granulomatous dermatitis associated with pulmonary coccidioidomycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Granuloma annulare with a mycosis fungoides-like distribution and palisaded granulomas of CD68-positive histiocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Patch granuloma annulare: clinicopathologic study of 6 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Intravascular or intralymphatic histiocytosis associated with rheumatoid arthritis: a report of 4 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Interstitial granulomatous drug reaction caused by Chinese herbal medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

A granuloma annulare-like eruption associated with the use of amlodipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Injection site reactions with the HIV-1 fusion inhibitor enfuvirtide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Lichenoid and granulomatous dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Sarcoidosis in untreated chronic hepatitis C virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Papular sarcoidosis of the knees: a clue for the diagnosis of erythema nodosum-associated sarcoidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Scar sarcoidosis after hyaluronic acid injection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Foreign bodies in sarcoidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Systemic sarcoidosis presenting with multiple tattoo granulomas and an extra-tattoo cutaneous granuloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Development of sarcoidosis in cosmetic tattoos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

The histologic spectrum of cutaneous sarcoidosis: a study of twenty-eight cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

The use of tetracyclines for the treatment of sarcoidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Infliximab therapy for sarcoidosis (lupus pernio).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Recalcitrant cutaneous sarcoidosis responding to infliximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Generalized granuloma annulare: clinical and laboratory findings in 100 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Granuloma annulare and malignant neoplasms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Precipitating factors and associated diseases in 84 patients with granuloma annulare: a retrospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Localized granuloma annulare is associated with insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Glucose tolerance in granuloma annulare.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Subcutaneous granuloma annulare in childhood: clinicopathologic features in 34 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Expression of IFNgamma, coexpression of TNFalpha and matrix metalloproteinases and apoptosis of T lymphocytes and macrophages in granuloma annulare

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Temporary remission of disseminated granuloma annulare under oral isotretinoin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Generalized granuloma annulare in a patient with acquired immunodeficiency syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Remission of human immunodeficiency virus-associated generalized granuloma annulare under zidovudine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Perforating granuloma annulare in a patient with acquired immunodeficiency syndrome. Immunohistologic evaluation of the cellular infiltrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Granuloma annulare and human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Disseminated granuloma annulare as a presentation of acquired immunodeficiency syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

[Generalized granuloma annulare and drug-induced immunodeficiency]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Interferon-alpha-associated sarcoidosis responsive to infliximab therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Cyclosporin for the treatment of granuloma annulare

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Isotretinoin in the treatment of granuloma annulare

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Improvement of chronic generalized granuloma annulare with isotretinoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Resolution of disseminated granuloma annulare with isotretinoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Rapid improvement of recalcitrant disseminated granuloma annulare upon treatment with the tumour necrosis factor-alpha inhibitor, infliximab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Collagenolytic (necrobiotic) granulomas: part II--the 'red' granulomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Necrobiosis lipoidica diabeticorum: A clinicopathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Necrobiosis lipoidica diabeticorum: association with background retinopathy, smoking, and proteinuria. A case controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Necrobiosis lipoidica--involvement of atypical sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Necrobiosis lipoidica diabeticorum in children and adolescents: a clue for underlying renal and retinal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Necrobiosis lipoidica diabeticorum: response to pentoxiphylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Ulcerated necrobiosis lipoidica treated with cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Healing of severe ulcerative necrobiosis lipoidica with cyclosporin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Clearance of necrobiosis lipoidica with fumaric acid esters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Ulcerated necrobiosis lipoidica: a combined treatment approach with dermatosurgery and PUVA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Histopathology of necrobiotic xanthogranuloma with paraproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Necrobiotic xanthogranuloma with two monoclonal paraproteins and no periorbital involvement at presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Necrobiotic xanthogranuloma with eye involvement. Overview and case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Recombinant interferon alfa-2b treatment of necrobiotic xanthogranuloma with paraproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Plasmapheresis, a treatment modality for necrobiotic xanthogranuloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Complement consumption in a patient with necrobiotic xanthogranuloma and paraproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Necrobiotic xanthogranuloma occurring within linear morphoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Rheumatoid nodulosis: report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

The HLA-DRB1*0401 allele and the development of methotrexate-induced accelerated rheumatoid nodulosis: a follow-up study of 79 Caucasian patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Accelerated nodulosis during azathioprine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

Necrobiosis lipoidica: treatment with systemic corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2006.09.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YADR.2006.09.005

1 reference

15 August 2017

1 reference